Histone deacetylase inhibitors (HDIs) have attracted considerable attention for anticancer therapy strategy, including radiosensitization. Regarding a potential application of HDI as a radiosensitizer in the treatment of solid tumors, an important question is whether treatment efficacy would be influenced by intrinsic differences between cancer cells, such as different histologic origin and status of ATM or p53. First we have observed the in vitro radiosensitization by Trichostatin A (TSA) on the broad spectrum of human tumor cell lines having different histologic origin such as HCT116 adenocarcinoma of colon, A549 adenocarcinoma of lung, HN-3 squamous cell carcinoma of head/neck, and HeLa squamous cacinoma of uterine cervix, using clonogenic assay. Next, we have systematically assessed the radiosensitization on the cell lines having different ATM or p53 status. We found that pretreatment of HDI consistently resulted in radiosensitization of all cell lines tested, though the sensitizer enhancement ratio of individual cell lines was variable. We also observed that TSA-mediated radiosensitization was clearly influenced by p53 and ATM status of cells tested. The data presented here indicate that HDI enhances the radiation induced cell killing in the various cancer cells having intrinsic differences and may serve as a general strategy for enhancing tumor cell radiosensitivity. These results have potential implications for the clinical utility of HDI in increasing the anticancer efficacy of radiation.
INTRODUCTION
Chromatin remodeling is an important mechanism in epigenetic regulation of gene expression. Generally, transcriptionally active genes are associated with highly acetylated core histones. Chromatin structure plays a major role in regulating the expression of the genetic information encoded in DNA. DNA is packaged into nucleosomes, the repeating units of chromatin, composed of -146 base pairs of two superhelical structure turns of DNA wrapped around an octamer core of pairs of histones H2A, H2B, H3 and H4. The posttranslational modifications in gene regulation include acetylation of lysines, methylation of lysine and phosphorylation of serine. 1) Accumulation of acetylated histones is associated with a neutralization of lysine-positive charge leading to an alteration in chromatin conformation, which may provide greater access to promoter regions of genes for transcription factor complexes. The pattern of acetylation of histones as well as the pattern of methylation and phosphorylation of histones may represent a "code" that is recognized by nonhistone complexes involved in the regulation of gene expression. 2) Histone acetyl transferase (HAT) and histone deacetylase (HDAC) are involved in acetylation or deacetylation not only of chromatin proteins, which can lead to altered regulation of transcription of genes but also of nonhistone proteins themselves controlling cell-cycle progression, differentiation, and/or apoptosis. To date, several inhibitors of HDACs with different chemical features have been reported in arresting cancer cell growth, with little toxicity. These compounds have been known to inhibit the activity of partially purified HDACs, to cause reversion of transformed morphology and inhibition of cell proliferation by induction of cell cycle arrest in G1 and/or G2 phase, terminal differentiation, and/or apoptosis of broad range of cell lines including solid tumors and hematologic malignancies. [3] [4] [5] [6] [7] [8] [9] The anticancer potential of HDAC inhibitors (HDIs) stems from their ability to affect several cellular processes, which are not well regulated in cancer cells. For the most part, activation of differential programs, inhibition of the cell cycle, and the induction of apoptosis are the key antitumor activities of HDIs. In addition, activation of host immune response and inhibition of angiogenesis might also have important roles in HDI mediated tumor regression in vivo. 4, 5, [9] [10] [11] Regarding a potential application of HDI in the treatment of solid tumors, an important question is whether treatment efficacy would be influenced by intrinsic differences between cancer cells, such as different histology, site of origin and status of ATM or p53. First, we have observed the in vitro radiosensitization by a typical HDI, Trichostatin A (TSA) on the cell lines having different histologies and sites of origin such as head/neck, lung, cervix and colon. Next, we have assessed the radiosensization on cell lines having different p53 and ATM status. We have tried to find that pretreatment of HDI consistently resulted in radiosensization of all cell lines tested. These results have potential implications for the clinical utility of HDI in increasing anticancer efficacy of radiation.
MATERIALS AND METHODS

Cell culture
Cell lines (HCT116 adenocarcinoma of colon, A549 adenocarcinoma of lung, HN-3 squamous cell carcinoma of head/neck, and HeLa squamous cacinoma of uterine cervix) were obtained from the Korean Cell Line Bank. AT5VA, LM217, and RKO cell lines were generously provided by Dr. Eun Kyeong Choi (Ulsan University, Ulsan, Korea). Cells were cultured at 37°C in water saturated with 5% CO 2 . Cultures were maintained in DMEM (Welgene, Daegu, Korea) or RPMI media (Gibco, Grand Island, NY) supple- mented with 10% fetal bovine serum and 12.5 μg/ml gentamicin (Gibco), respectively.
Pharmacologic inhibitors
TSA was obtained from Sigma Chemical Co. (St Louis, MO) and were dissolved as concentrated stock solutions in DMSO, stored at -20°C, and diluted at the time of use in culture medium. Control cells were treated with medium containing an equal concentration of DMSO.
Clonogenic assays
A specified number of cells were seeded into each wells of six well culture plates and treated with IC50 (100-200 nM) for TSA. After exposure for 18 hours, the cells were irradiated with 4 MV X-ray from a linear accelerator (Clinac 4/100, Varian Medical Systems, Palo Alto, CA) at a dose rate of 2.46 Gy/min and were incubated for colony formation for 14 -21 days. Colonies were fixed with methanol and stained with 0.5% crystal violet, the number of colonies containing at least 50 cells was determined and surviving fraction were calculated. Survival data were fitted to a linear-quadratic model using Kaleidagraph version 3.51 (Synergy Software, Reading, PA). Each point on the survival curves represents the mean surviving fraction from at least three dishes.
Western analysis
Cells were treated in cold lysis buffer (iNtRON Biotechnology, Seoul, Korea), sonicated, kept on ice for 30 min, centrifuged at 13,000 g for 20 minutes at 4°C, and supernatant was collected. Samples containing equal amounts of protein were separated on SDS-PAGE and electrophoretically transferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA). Membranes were blocked in PBS containing 0.1% Tween 20 and 5% powdered milk and probed with primary antibody directed against polyclonal rabbit anti-acetyl-histone H3 IgG (Upstate Biotechnology, Lake Placid, NY) at 1:1,000 dilution, monoclonal anti-α-tubulin antibody (Sigma, St. Louis, MO) at a 1:5,000 dilution. The membranes were washed, and then incubated with secondary antibody consisting of peroxidase-conjugated goat anti-rabbit or mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) at a 1:2,000 dilution for 1 hour. Detection of antibody binding was done using the ECL detection kit from Amersham using the appropriate secondary antibody supplied with the kit.
Analysis of cell cycle phase distribution following irradiation
A549 cells were pretreated with 0 or 200 nM TSA for 18 hr, and then irradiated with 0, 2, or 8 Gy. At 2-24 hr after irradiation, cells were collected, fixed, stained with propidium iodide, and analyzed using FACscan flow cytometry (Becton Dickinson, Franklin Lakes, NJ).
RESULTS
Consistent radiosensitization on the cells with different histologic origins
As an initial evaluation of the radiosensitizing effects of TSA on the various tumor cell lines having different histologic origin, HCT116 adenocarcinoma cells of colon, A549 adenocarcinoma cells of lung, HN-3 squamous cells of head/ neck and HeLa cells from uterine cervix were used for clonogenic assays (Fig. 1A-B and 2A-B) . Pretreatment of TSA for 18 hours before radiation increased acetylation of histone H3, and consistently enhanced the radiation-induced cell killing in the cell lines we tested. Sensitizer enhancement ratio of individual cell line was variable (Table 1 )
Radiosensitization on the cells with different p53 status
We previously reported that the level of radiosensitization by TSA was clearly influenced by p53 expression status via genetic or pharmacologic modification of p53 expression under isogenic background. 12) In this study, we observed different level of radiosensitization depending on the level of p53 expression; p53 proficient cells such as A549 and HCT116 showed higher sensitizer enhancement ratios (SER) than those of p53 deficient cells such as HeLa and HN-3 ( Fig. 1 vs. 2) .
Radiosensitization on the cells with different ATM status
We next investigated whether radiosensitizing effect of TSA might be determined by ATM status using two different cell lines having different ATM status (AT vs. LM). Interestingly, we found that the level of TSA mediated radiosensitization was dramatically changed by ATM status of these cell lines. LM cells having normal ATM status showed significantly greater radiosensitization by TSA (SER 3.0) than AT cells (SER 1.9) having mutant ATM status (Fig. 3) . Having found that TSA more potently radiosensitize the fibroblast having normal ATM, we would like to confirm this in tumor cells having isogenic background. RKO-ATM cells, a colon cancer cells having mutant ATM showed significantly less radiosensitization by TSA (SER 1.4), compared to that of parental cells (SER 2.4) (Fig. 4) .
TSA abrogated radiation induced G2 arrest
The DMSO-treated control cells were accumulated in the G2/M phase after irradiation in a radiation dose dependent manner. Brief episode of moderate G2/M arrest was observed with peak at 6 hours and returning to basal level at 10 to 12 hours following irradiation at the dose of 2 Gy. In this case, G2/M proportion was increased less than 20% of basal level ( There is no doubt that in the relatively short time since the discovery of HDACs great progress has been made both in the understanding of mediators of gene silencing as well as in the translation of this knowledge into potential clinical use. While gene re-expression may be a reason for the success of HDIs in preclinical and clinical studies, 13, 14) it is not the only factor. HDIs can display pleiotropic effects, including inhibition of cell cycle progression, differentiation, apoptosis and anti-proliferative effects. 3, 4, 10) In addition, many studies have indicated that combining HDIs with ionizing radiation results in an enhanced anti-cancer effect. [15] [16] [17] [18] [19] [20] [21] [22] Because chromatin DNA is tightly compacted, accessibility to the drug target DNA or enzymes acting on DNA may reduce the efficiency of these anticancer drugs. Looseningup the chromatin structure by histone acetylation can increase the efficiency of several anticancer drugs targeting DNA. 17) Our studies suggest that radiosensitization by TSA would be a rather general phenomenon, i.e., one that is not confined to specific types of tumor cells. Other investigators have also reported that HDIs induced radiosensitization. [15] [16] [17] [18] [19] [20] In view of the fact that HDIs with dissimilar chemical structures have the radiosensitizing effect in common, it appears that HDAC is involved in the cellular response to ionizing radiation. We observed that TSA exposure sensitized all tested cell lines to radiation, although they showed different susceptibilities to TSA, and their radiosensitivities were affected differently by TSA. Thus, it is quite likely that cellular radiosensitivity is closely related with DNA repair mechanisms; cellular response to DNA damage comprises the recognition of DNA breaks by surveillance proteins, the signal transduction, and the activation of effecter proteins. Evidences exist that HDACs play a crucial role in the recognition and repair process of DNA damage. DNA-dependent protein kinase, ATM, and ATR act as sensors of DNA damage. [22] [23] On recognizing DNA breaks, these proteins transmit signals to downstream cascades, which lead to the expression and activation of effecter proteins, and culminate in cell cycle arrest, DNA repair, and apoptosis. Furthermore, it has been reported that radiation enhances the interaction between HDAC and ATM. 22) In addition, it was shown that HDAC4 colocalizes with γH2AX at sites of DNA damage in irradiated cells, suggesting that HDAC is involved in γH2AX-mediated DNA damage recognition or the DNA repair mechanism. 24) We recently have reported that pretreatment of LBH589 prolonged γH2AX foci expression in irradiated cells. 21) These findings suggest that HDAC is closely involved in early steps of cellular response to ionizing radiation, and that this response can be modulated by HDIs. Current study also shows that the cells having mutant ATM showed significant less sensitization by TSA. This finding indicates that ATM is mechanistically involved in HDAC-mediated radiosensitization. The precise mechanism of this protein which potentiates radiosensitization by TSA needs to be defined. p53 tumor suppressor is a critical component in the cellular response to DNA damage. 25) Both the physical stability and biological activity of p53 depend on its phosphorylation at specific Ser residues in response to DNA damage. Acetylation also plays an important role in stabilizing and augmenting p53. HATs, such as p300 and PCAF, acetylate p53 at Lys residues in its C-terminal region, rendering it resistant to MDM2-mediated degradation. 26) We previously reported that radiosensitization by TSA in the cells expressing p53 more pronounced than the cells lacking p53 using genetic and pharmacologic modification of p53 level. 12) G2/M checkpoint in irradiated cells is implicated as a determining factor of cellular radiosensitivity. 27) G2 arrest is actually an active response with a role in DNA repair, and ATM is thought to direct DNA damage signals down to the G2 checkpoint machinery level to arrest irradiated cells. We also have observed that pretreatment of TSA led abrogation of G2 checkpoint in previous 12, 18) and current studies. The exact mechanism for the abrogation of radiation-induced G2 delay by TSA will be the next topic of our future investigation.
The aforementioned findings suggest that HDAC is extensively involved in cellular response to ionizing radiation, and mean that HDAC provides potential molecular steps, which can be targeted by HDI at multiple levels of cellular response to radiation-induced DNA damage. It is known that HDACs, in the context of their role in DNA damage response, may be targeted at some specific steps between DNA damage recognition and G2/M checkpoint. Nome et al. suggested that HDI decreases the time available for DNA damage repair. 28) Taddei et al also showed that HDAC activity was required for maintaining pericentric heterochromatin. 29) We recently have reported that LBH589, a hydroxamic acid compound, enhanced radiosensitivity of a panel of cells we tested. Abrogation of radiation-induced G2 arrest, prolongation of γH2AX foci, and aberrant mitotic features were common mechanistic elements of radiosensitization. LBH589 radiosensitized cells with activated EGFR or HER-2 signaling to a greater degree than the HDIs TSA or SK7041. LBH589 led down-regulation of EGFR or HER-2 signaling by acetylation HSP90 via effective inhibition of HDAC6. 21) Although these findings define a unique mechanism of radiosensitization by HDAC inhibition, diverse mechanisms of radiosensitization by HDIs still remain to be defined.
In conclusion, the data presented here indicate that HDI enhances the radiation induced cell killing in the various cancer cells having intrinsic difference and may serve as a general strategy for enhancing tumor cell radiosensitivity. These results have potential implications for the clinical utility of HDI in increasing the anticancer efficacy of radiation.
